Hypofractionation Benefits for SRS Treatments in Patients with Large Brain Metastases
Ufuk Abacioglu, MD, from NEOLIFE Medical Center in Istanbul discusses the benefits of hypofractionation for stereotactic radiosurgery treatments for patients with large brain metastases. He begins by addressing how surgery is the standard treatment for large brain metastases, as well as the limitations thereof. He then delves into the factors that influence the decision to fractionate radiosurgery treatments for larger metastases, giving case examples as well as data analysis from various studies.
About the speaker
Related Videos
-
The Emerging Role of Stereotactic Radiosurgery as an Adjuvant to Surgical Resections
-
Dosimetric Analysis and Clinical Validation for the Automatic Brain Metastasis Planning
-
First Clinical Treatments Utilizing the Automatic Brain Metastases Planning Element
-
The NeuroPoint Alliance National Radiosurgery Registry
-
A Growing Need for Neurocognitive Assessment Tools
-
Clinical Evidence and Practice Guidelines
-
Hypo-Fractionation Benefits for Stereotactic Radiosurgery Treatments in Patients with Large Brain Metastases
-
First Clinical Applications of ExacTrac Dynamic
Interested in watching this clinical talk? Please click on the button “WATCH Video” to enter your contact details and to have access to two additional videos from the member-only Novalis Circle. Your contact information will only be used to contact you about Novalis Video related updates.
WATCH VideoKeep Watching
Thank you for watching! Please enter your contact details below to continue watching and to have access to two additional videos from the member-only Novalis Circle. Your contact information will only be used to contact you about Novalis Circle video related updates.
Watch video No ThanksAlready Novalis Circle Member?
Member LoginRegister now
Thank you for your interest in our Novalis Circle videos. Full-access to the media library is currently available for Novalis Radiosurgery users only. If you are a customer, please register or login to continue.